Urinary metabolic phenotyping for Alzheimer’s disease

[1]  Noureddin Sadawi,et al.  The nPYc-Toolbox, a Python module for the pre-processing, quality-control and analysis of metabolic profiling datasets , 2019, Bioinform..

[2]  G. Brewer,et al.  Global Metabolic Shifts in Age and Alzheimer’s Disease Mouse Brains Pivot at NAD+/NADH Redox Sites , 2019, Journal of Alzheimer's disease : JAD.

[3]  J. Nicholson,et al.  Systematic Isolation and Structure Elucidation of Urinary Metabolites Optimized for the Analytical-Scale Molecular Profiling Laboratory , 2019, Analytical Chemistry.

[4]  Beatrice Aramini,et al.  A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology , 2019, Scientific Reports.

[5]  A. Garg,et al.  Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function , 2019, Scientific Reports.

[6]  D. Campion,et al.  SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data , 2019, Acta Neuropathologica.

[7]  Isabel Meister,et al.  Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics. , 2019, Current opinion in biotechnology.

[8]  Dag Aarsland,et al.  Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration , 2019, Acta neuropathologica communications.

[9]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[10]  Xianlin Han,et al.  Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome , 2018, Alzheimer's & Dementia.

[11]  S. An,et al.  Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease , 2018, Nutrients.

[12]  Fedor V. Karginov,et al.  Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs , 2018, Scientific Reports.

[13]  H. Meltzer,et al.  Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction , 2018, Behavioural Brain Research.

[14]  M. Buffelli,et al.  Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease , 2018, Acta neuropathologica communications.

[15]  Tiangang Li,et al.  Bile acids regulate cysteine catabolism and glutathione regeneration to modulate hepatic sensitivity to oxidative injury. , 2018, JCI insight.

[16]  L. Ferrucci,et al.  Evidence for brain glucose dysregulation in Alzheimer's disease , 2018, Alzheimer's & Dementia.

[17]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[18]  T. Iwaki,et al.  Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation , 2017, Scientific Reports.

[19]  G. Kemmler,et al.  Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease , 2017, Metabolomics.

[20]  Sterling C. Johnson,et al.  Gut microbiome alterations in Alzheimer’s disease , 2017, Scientific Reports.

[21]  Philip Scheltens,et al.  Blood-based metabolic signatures in Alzheimer's disease , 2017, Alzheimer's & dementia.

[22]  A. Zhang,et al.  High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease. , 2017, Journal of proteome research.

[23]  J. Estep,et al.  The RacGAP β-Chimaerin is essential for cerebellar granule cell migration , 2017, Scientific Reports.

[24]  J. Belisle,et al.  Elucidating the Structure of N1-Acetylisoputreanine: A Novel Polyamine Catabolite in Human Urine , 2017, ACS omega.

[25]  D. Absher,et al.  Genome- and CD4+ T-cell methylome-wide association study of circulating trimethylamine-N-oxide in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). , 2017, Journal of nutrition & intermediary metabolism.

[26]  C. Hölscher,et al.  Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer’s Disease , 2017, Metabolites.

[27]  K. Lunetta,et al.  Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans , 2017, Alzheimer's & Dementia.

[28]  M. Lovell,et al.  Multiregional analysis of global 5‐methylcytosine and 5‐hydroxymethylcytosine throughout the progression of Alzheimer's disease , 2017, Journal of neurochemistry.

[29]  Michelle K. Lupton,et al.  Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis , 2017, Alzheimer's & Dementia.

[30]  P. Snyder,et al.  Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic , 2017, Alzheimer's & Dementia.

[31]  J. S. Smith,et al.  Ab initio calculation of energy levels for phosphorus donors in silicon , 2016, Scientific Reports.

[32]  K. Blennow,et al.  The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[33]  P. Elliott,et al.  Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping. , 2016, Analytical chemistry.

[34]  V. Gudnason,et al.  Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals , 2016, Alzheimer's & Dementia.

[35]  K. Blennow,et al.  CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis , 2016, The Lancet Neurology.

[36]  D. Wesson,et al.  Alterations of the volatile metabolome in mouse models of Alzheimer’s disease , 2016, Scientific Reports.

[37]  G. Breen,et al.  Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins , 2016, Translational psychiatry.

[38]  A. Lindsay,et al.  Realising the Potential of Urine and Saliva as Diagnostic Tools in Sport and Exercise Medicine , 2016, Sports Medicine.

[39]  Youhe Gao,et al.  Urinary Biomarkers of Brain Diseases , 2015, Genom. Proteom. Bioinform..

[40]  M. Nalls,et al.  Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease , 2015, Front. Neurol..

[41]  K. Kashiwagi,et al.  Evaluation of dementia by acrolein, amyloid-β and creatinine. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[42]  L. Moezi,et al.  The effects of intra-dorsal hippocampus infusion of pregnenolone sulfate on memory function and hippocampal BDNF mRNA expression of biliary cirrhosis-induced memory impairment in rats , 2015, Neuroscience.

[43]  Christian Gieger,et al.  Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality , 2015, PLoS genetics.

[44]  Wen Dong,et al.  The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment , 2015, Journal of Clinical Neuroscience.

[45]  Yumei Li,et al.  Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer’s disease in patients with the apolipoprotein E ε4 genotype , 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[46]  Yuliya V. Karpievitch,et al.  Metabolomics Data Normalization with EigenMS , 2014, PloS one.

[47]  M. Spraul,et al.  Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. , 2014, Analytical chemistry.

[48]  D. Wishart,et al.  Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease. , 2014, Journal of proteome research.

[49]  Magda Tsolaki,et al.  Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis , 2014, PLoS medicine.

[50]  N. Kitamura,et al.  Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease , 2014, Translational Psychiatry.

[51]  Stefan Teipel,et al.  CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease , 2014, Alzheimer's & Dementia.

[52]  Olivier Colliot,et al.  Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. , 2014, Biochemical pharmacology.

[53]  R. Bruick,et al.  F-box and leucine-rich repeat protein 5 (FBXL5): sensing intracellular iron and oxygen. , 2014, Journal of inorganic biochemistry.

[54]  Derick R. Peterson,et al.  Plasma phospholipids identify antecedent memory impairment in older adults , 2014, Nature Medicine.

[55]  Christoph Steinbeck,et al.  Genome-Wide Association Study of Metabolic Traits Reveals Novel Gene-Metabolite-Disease Links , 2014, PLoS genetics.

[56]  K. Roszkowski.  Oxidative DNA damage--the possible use of biomarkers as additional prognostic factors in oncology. , 2014, Frontiers in bioscience.

[57]  Harald Hampel,et al.  Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease , 2014, Neuropsychopharmacology.

[58]  Wei Liu,et al.  CORRIGENDUM: Biodegradation-inspired bioproduction of methylacetoin and 2-methyl-2,3-butanediol , 2013, Scientific Reports.

[59]  T. Toyo’oka,et al.  Metabolic profiling of Alzheimer's disease brains , 2013, Scientific Reports.

[60]  M. Pericak-Vance,et al.  Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP) , 2013, Translational Psychiatry.

[61]  S. Niida,et al.  NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: identification of oxidative stress biomarkers , 2013, Journal of clinical biochemistry and nutrition.

[62]  P. S. St George-Hyslop,et al.  Vps10 Family Proteins and the Retromer Complex in Aging-Related Neurodegeneration and Diabetes , 2012, The Journal of Neuroscience.

[63]  C. Reitz.  The role of intracellular trafficking and the VPS10d receptors in Alzheimer's disease. , 2012, Future neurology.

[64]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[65]  J. Nicholson,et al.  Genetic determinants of metabolism in health and disease: from biochemical genetics to genome-wide associations , 2012, Genome Medicine.

[66]  S. Correia,et al.  Metabolic Alterations Induced by Sucrose Intake and Alzheimer’s Disease Promote Similar Brain Mitochondrial Abnormalities , 2012, Diabetes.

[67]  Andrey A. Shabalin,et al.  Matrix eQTL: ultra fast eQTL analysis via large matrix operations , 2011, Bioinform..

[68]  M. Şeneş,et al.  Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease , 2012, Clinical chemistry and laboratory medicine.

[69]  J. Marchini,et al.  Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.

[70]  Peter Donnelly,et al.  A Genome-Wide Metabolic QTL Analysis in Europeans Implicates Two Loci Shaped by Recent Positive Selection , 2011, PLoS genetics.

[71]  Xianlin Han,et al.  Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics , 2011, PloS one.

[72]  J. Loscalzo.  Lipid metabolism by gut microbes and atherosclerosis. , 2011, Circulation research.

[73]  J. Newton,et al.  Functional capacity is significantly impaired in primary biliary cirrhosis and is related to orthostatic symptoms , 2011, European journal of gastroenterology & hepatology.

[74]  Christian Gieger,et al.  A genome-wide association study of metabolic traits in human urine , 2011, Nature Genetics.

[75]  J. T. Greenamyre,et al.  Mitochondrial iron metabolism and its role in neurodegeneration. , 2010, Journal of Alzheimer's disease : JAD.

[76]  A. Paterson,et al.  Genome-Wide Association Identifies the ABO Blood Group as a Major Locus Associated With Serum Levels of Soluble E-Selectin , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[77]  A. Simmons,et al.  AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.

[78]  A. Simmons,et al.  MRI Measures of Alzheimer's Disease and the AddNeuroMed Study , 2009, Annals of the New York Academy of Sciences.

[79]  A. Blamire,et al.  Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology , 2008, Hepatology.

[80]  S. Lovestone,et al.  Diagnosing Alzheimer's disease—non‐clinicians and computerised algorithms together are as accurate as the best clinical practice , 2007, International journal of geriatric psychiatry.

[81]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[82]  G. Hu,et al.  Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease. , 2007, Life sciences.

[83]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[84]  S. Lovestone,et al.  Proteome-based plasma biomarkers for Alzheimer's disease. , 2006, Brain : a journal of neurology.

[85]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[86]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[87]  Ruben Abagyan,et al.  A Metabolite Mass Spectral Database , 2005 .

[88]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[89]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[90]  D. Abrous,et al.  Pregnenolone Sulfate and Aging of Cognitive Functions: Behavioral, Neurochemical, and Morphological Investigations , 2001, Hormones and Behavior.

[91]  Tin Kam Ho,et al.  The Random Subspace Method for Constructing Decision Forests , 1998, IEEE Trans. Pattern Anal. Mach. Intell..

[92]  W. Griffiths,et al.  The identification of novel steroid N-acetylglucosaminides in the urine of pregnant women , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[93]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[94]  S. Matern,et al.  Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans. , 1992, The Journal of clinical investigation.

[95]  L. Romanoff,et al.  Effect of age on pregnanediol excretion by men. , 1970, Journal of gerontology.